Catalog No. | HW632066 |
---|---|
Species reactivity | Human |
Applications | Research Grade Biosimilar |
Host species | Humanized |
Isotype | IgG1-kappa |
Expression system | Mammalian Cells |
Species | Human |
Clonality | Monoclonal |
Target | IL13, NC30, Interleukin-13, IL-13 |
Endotoxin level | Please contact with the lab for this information. |
Purity | >95% as determined by SDS-PAGE. |
Purification | Protein A/G purified from cell culture supernatant. |
Accession | P35225 |
Form | Liquid |
Storage buffer | 0.01M PBS, pH 7.4. |
Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. |
Alternate Names | IMA-638, CAS: 910649-32-0 |
Background | Anrukinzumab (IMA-638) is a humanized anti-IL-13 monoclonal antibody. Anrukinzumab effectively reduces lung inflammation in a cynomolgus monkey model. Anrukinzumab can be used in studies of ulcerative colitis (UC) as well as asthma. |
Note | For research use only. Not suitable for clinical or therapeutic use. |
Detects recombinant human IL13 (Cat No.: HW632012) in indirect ELISA.
+33(0)3 90 20 54 70
19 rue de la Haye 67300 Schiltigheim France